The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
Open accessAbstract
Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity both in generally healthy persons and in those with known ASCVD. The foundation of preventive cardiology begins with assessing baseline ASCVD risk using global risk scores based on standard office-based measures. Persons at low risk are generally recommended for lifestyle management only and those at highest risk are recommended for both lifestyle and pharmacologic therapy. Additional "risk enhancing" factors, including both traditional risk factors and novel biomarkers and inflammatory factors can be used to further assess ASCVD risk, especially in those at borderline or intermediate risk. There are also female-specific risk enhancers, social determinants of health, and considerations for high-risk ethnic groups. Screening for subclinical atherosclerosis, especially with the use of coronary calcium screening, can further inform the treatment decision if uncertain based on the above strategies. Persons with pre-existing ASCVD also have variable risk, affected by the number of major ASCVD events, whether recurrent events have occurred recently, and the presence of other major risk factors or high-risk conditions. Current guidelines define high to very high risk ASCVD accordingly. Accurate ASCVD risk assessment is crucial for the appropriate targeting of preventive therapies to reduce ASCVD risk. Finally, the clinician-patient risk discussion focusing on lifestyle management and the risks and benefits of evidence-based pharmacologic therapies to best lower ASCVD risk is central to this process. This clinical practice statement provides the preventive cardiology specialist with guidance and tools for assessment of ASCVD risk with the goal of appropriately targeting treatment approaches for prevention of ASCVD events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Khan, S. U., Yedlapati, S. H., Lone, A. N., Khan, M. S., WENGER, N. K., Watson, K. E., Gulati, M., Hays, A. G., & Michos, E. D. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa099 · Cited by 55
Self-citationIschemic Event Rates in Very-High-Risk Adults
Colantonio, L. D., Shannon, E., Orroth, K. K., Zaha, R. L., Jackson, E. A., Rosenson, R. S., Exter, J., Mues, K. E., & Muntner, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.025 · Cited by 54
Physicians' ability to predict the risk of coronary heart disease
Pignone, M. P., Phillips, C. J., Elasy, T. A., & Fernández, A. (2003) · BMC Health Services Research · doi:10.1186/1472-6963-3-13 · Cited by 51
Lubrano, V., Turco, S. D., Nicolini, G., Cecco, P. D., & Basta, G. (2008) · Lipids · doi:10.1007/s11745-008-3227-9 · Cited by 51
Ahmadi, N., Nabavi, V., Nuguri, V., Hajsadeghi, F., Flores, F. R., Akhtar, M. W., Kleis, S. J., Hecht, H. S., Naghavi, M., & Budoff, M. J. (2009) · International journal of cardiac imaging · doi:10.1007/s10554-009-9476-8 · Cited by 51
Self-citationZhao, M., Cooney, M. T., Klipstein‐Grobusch, K., Vaartjes, I. C. H., Bacquer, D. D., SUTTER, J. D., Reiner, Ž., Prescott, E., Faggiano, P. M., Vanuzzo, D., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316647827 · Cited by 50
Self-citationMoonesinghe, R., Yang, Q., Zhang, Z., & Khoury, M. J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012364 · Cited by 48
Wong, N. D., Hsu, A. R. C., Rozanski, A., Shaw, L. J., Whelton, S. P., Budoff, M. J., Nasir, K., Miedema, M. D., Rumberger, J. A., Blaha, M. J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0166 · Cited by 48
Self-citationPrognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis
Buchan, T. A., Ching, C., Foroutan, F., Malik, A., Daza, J. F., Hing, N. N. F., Siemieniuk, R. A. C., Evaniew, N., Orchanian‐Cheff, A., Ross, H. J., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10136-3 · Cited by 48
Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
Elgendy, I. Y., Nadeau, S. E., Merz, C. N. B., Pepine, C. J., Lindley, K. J., Lindley, K. J., Reynolds, H. R., Harmony, M. D., Volgman, A. S., Asgar, A., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.014546 · Cited by 45
Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups
Makshood, M., Joshi, P. H., Kanaya, A. M., Ayers, C. R., Budoff, M. J., Tsai, M. Y., Blaha, M. J., Michos, E. D., & Post, W. S. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.010 · Cited by 44
Self-citationMichos, E. D., Blaha, M. J., & Blumenthal, R. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.10.001 · Cited by 43
Self-citationPeng, W. H., Jian, W. X., Li, H. L., Hou, L., Wei, Y. D., Li, W. M., & Xu, Y. W. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-41 · Cited by 41
Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family
Bujo, H., & Saitō, Y. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000219692.78477.17 · Cited by 40
Rifai, M. A., Blaha, M. J., Nambi, V., Shea, S. J. C., Michos, E. D., Blumenthal, R. S., Ballantyne, C. M., Szklo, M., Greenland, P., Miedema, M. D., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056705 · Cited by 40
Self-citationZhao, Z., Zhu, X., Luo, Y., Lin, C., & Chen, L. (2011) · Clinical Cardiology · doi:10.1002/clc.20847 · Cited by 37
Cardiac Troponins As Biomarkers for Cardiac Disease
Passino, C., Aimo, A., Masotti, S., Musetti, V., Prontera, C., Emdin, M., & Clerico, A. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0039 · Cited by 37
Myeloid-related protein-8/14 in acute coronary syndrome
Sakuma, M., Tanaka, A., Kotooka, N., Hikichi, Y., Toyoda, S., Abe, S., Taguchi, I., Node, K., Simon, D. I., & Inoue, T. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.09.020 · Cited by 30
Vallejo‐Vaz, A. J., Ray, K. K., Ginsberg, H. N., Davidson, M. H., Eckel, R. H., Lee, L. V., Bessac, L., Pordy, R. C., Letierce, A., & Cannon, C. P. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.008 · Cited by 30
Maiseyeu, A., Badgeley, M. A., Kampfrath, T., Mihai, G., Deiuliis, J. A., Liu, C., Sun, Q., Parthasarathy, S., Simon, D. I., Croce, K., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244509 · Cited by 28
Cairncross, Z. F., Ahmed, S. B., Dumanski, S. M., Nerenberg, K. A., & Metcalfe, A. (2020) · CJC Open · doi:10.1016/j.cjco.2020.11.011 · Cited by 26
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein
Sniderman, A. D., Tremblay, A., Graaf, J. D., & Couture, P. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.081 · Cited by 23
Postley, J. E., Luo, Y., Wong, N. D., & Gardin, J. M. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.031 · Cited by 18
Self-citationManjunath, L., Chung, S., Li, J., Shah, H. N., Palaniappan, L. P., & Yong, C. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014362 · Cited by 16
Rosario, K. F., Mehta, A., Ayers, C. R., Gonzalez, P. A. E., Pandey, A., Khera, R., Kaplan, R. C., Blaha, M. J., Khera, A., Blumenthal, R. S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018410 · Cited by 16
Utilizing coronary artery calcium to guide statin use
Golub, I. S., Lakshmanan, S., Dahal, S., & Budoff, M. J. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.04.011 · Cited by 16
Self-citationThe Association Between Multiparity and Adipokine Levels: The Multi-Ethnic Study of Atherosclerosis
Rodriguez, C. P., Ogunmoroti, O., Quispe, R., Osibogun, O. I., Ndumele, C. E., Tcheugui, J. E., Minhas, A., Bertoni, A. G., Allison, M., & Michos, E. D. (2021) · Journal of Women s Health · doi:10.1089/jwh.2021.0091 · Cited by 16
Self-citationLam, C. S. P., Castillo, R., Ho, D. T., Kasliwal, R. R., Khurana, R., Naik, S. R., Omland, T., Parsonage, W. A., Phrommintikul, A., Tobing, D., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.107 · Cited by 15
Волков, А. М., Murashov, I. S., Polonskaya, Y. V., Владимирович, С. С., Kazanskaya, G. M., Kliver, E. E., Ragino, Y. I., & Chernyavskiy, A. M. (2018) · Kardiologiia · doi:10.18087/cardio.2018.10.10180 · Cited by 14
Ferdinand, K. C., & Maraboto, C. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012457 · Cited by 14
Self-citationIs There a Role of Coronary CTA in Primary Prevention? Current State and Future Directions
Mortensen, M. B., & Blaha, M. J. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00943-2 · Cited by 12
US taskforce advises against low dose aspirin for primary prevention of cardiovascular disease
Mahase, E. (2021) · BMJ · doi:10.1136/bmj.n2521 · Cited by 8
ADIPOKINES AND PATHOPHYSIOLOGY OF PREGNANCY COMPLICATIONS – THE ROLE OF LEPTIN AND ADIPONECTIN
Mazaki‐Tovi, S., Vaisbuch, E., & Romero, R. J. (2013) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539514000011 · Cited by 7
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Frąk, W., Wojtasińska, A., Lisińska, W., Młynarska, E., Franczyk, B., & Rysz, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081938 · Cited by 303
Liu, T., Krentz, A., Lu, L., & Curcin, V. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztae080 · Cited by 177
Khan, S. S., Post, W. S., Guo, X., Tan, J., Zhu, F., Bos, D., Sedaghati-Khayat, B., van Rooij, J., Aday, A., Allen, N. B., et al. (2023) · JAMA · doi:10.1001/jama.2023.7575 · Cited by 117
Self-citationJarvis, P. R. E., Cardin, J. L., Nisevich-Bede, P. M., & McCarter, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155640 · Cited by 86
Charting the Unseen: How Non-Invasive Imaging Could Redefine Cardiovascular Prevention
Trimarchi, G., Pizzino, F., Paradossi, U., Gueli, I. A., Palazzini, M., Gentile, P., Di Spigno, F., Ammirati, E., Garascia, A., Tedeschi, A., et al. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11080245 · Cited by 45
Metadata
- Authors
- Wong, N. D., Budoff, M. J., Ferdinand, K., Graham, I. M., Michos, E. D., Reddy, T., Shapiro, M. D., & Toth, P. P.
- Venue
- American Journal of Preventive Cardiology
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 10
- Pages
- 100335
- ISSN
- 2666-6677 (ISSN-L)
- OpenAlex
- W4220696966
- Cited by
- 302
- References
- 234
- FWCI
- 47.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.